Literature DB >> 12510703

A review of atrial fibrillation.

David Dang1, Raluca Arimie, L Julian Haywood.   

Abstract

Atrial fibrillation (AF) is the most common sustained cardiac arrhythmia and accounts for more physician visits and hospital days than any other cardiac rhythm disturbance. Atrial filbrillation is incresing in frequency as the population ages, and therefore, a knowledge of the clinical spectrum and available treatment regimen is essential. Here, we review the pathophysiology, clinical presentation, and current status of management. Experience is being rapidly accumulated in all of the areas discussed in the management of this important clinical entity.

Entities:  

Mesh:

Year:  2002        PMID: 12510703      PMCID: PMC2568400     

Source DB:  PubMed          Journal:  J Natl Med Assoc        ISSN: 0027-9684            Impact factor:   1.798


  81 in total

1.  Routine platelet transfusion in patients undergoing emergency coronary bypass surgery after receiving abciximab.

Authors:  C P Juergens; A C Yeung; S N Oesterle
Journal:  Am J Cardiol       Date:  1997-07-01       Impact factor: 2.778

2.  Left ventricular dysfunction due to atrial fibrillation in patients initially believed to have idiopathic dilated cardiomyopathy.

Authors:  M Grogan; H C Smith; B J Gersh; D L Wood
Journal:  Am J Cardiol       Date:  1992-06-15       Impact factor: 2.778

3.  Classification of atrial fibrillation.

Authors:  M M Gallagher; A J Camm
Journal:  Pacing Clin Electrophysiol       Date:  1997-06       Impact factor: 1.976

4.  Risk for clinical thromboembolism associated with conversion to sinus rhythm in patients with atrial fibrillation lasting less than 48 hours.

Authors:  M J Weigner; T A Caulfield; P G Danias; D I Silverman; W J Manning
Journal:  Ann Intern Med       Date:  1997-04-15       Impact factor: 25.391

5.  The management of atrial fibrillation.

Authors:  D M Gilligan; K A Ellenbogen; A E Epstein
Journal:  Am J Med       Date:  1996-10       Impact factor: 4.965

6.  Risk of initiating antiarrhythmic drug therapy for atrial fibrillation in patients admitted to a university hospital.

Authors:  W H Maisel; K M Kuntz; S C Reimold; T H Lee; E M Antman; P L Friedman; W G Stevenson
Journal:  Ann Intern Med       Date:  1997-08-15       Impact factor: 25.391

7.  Prospective assessment of the minimum energy needed for external electrical cardioversion of atrial fibrillation.

Authors:  P Ricard; S Lévy; J Trigano; F Paganelli; E Daoud; K C Man; S A Strickberger; F Morady
Journal:  Am J Cardiol       Date:  1997-03-15       Impact factor: 2.778

8.  Identification of a genetic locus for familial atrial fibrillation.

Authors:  R Brugada; T Tapscott; G Z Czernuszewicz; A J Marian; A Iglesias; L Mont; J Brugada; J Girona; A Domingo; L L Bachinski; R Roberts
Journal:  N Engl J Med       Date:  1997-03-27       Impact factor: 91.245

9.  Efficacy and safety of repeated intravenous doses of ibutilide for rapid conversion of atrial flutter or fibrillation. Ibutilide Repeat Dose Study Investigators.

Authors:  B S Stambler; M A Wood; K A Ellenbogen; K T Perry; L K Wakefield; J T VanderLugt
Journal:  Circulation       Date:  1996-10-01       Impact factor: 29.690

10.  Effect of atrial fibrillation on atrial refractoriness in humans.

Authors:  E G Daoud; F Bogun; R Goyal; M Harvey; K C Man; S A Strickberger; F Morady
Journal:  Circulation       Date:  1996-10-01       Impact factor: 29.690

View more
  3 in total

Review 1.  Atrial fibrillation: review of current treatment strategies.

Authors:  Joshua Xu; Jessica G Y Luc; Kevin Phan
Journal:  J Thorac Dis       Date:  2016-09       Impact factor: 2.895

2.  Increased left atrial size is associated with higher atrial fibrillation recurrence in patients treated with antiarrhythmic medications.

Authors:  Saarang Mulukutla; Andrew D Althouse; Sandeep K Jain; Samir Saba
Journal:  Clin Cardiol       Date:  2018-06-07       Impact factor: 2.882

3.  Atrial fibrillation in a multiethnic inpatient population of a large public hospital.

Authors:  David Dang; Rajan Patel; L Julian Haywood
Journal:  J Natl Med Assoc       Date:  2004-11       Impact factor: 1.798

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.